Upgrade to SI Premium - Free Trial

Mizuho Reiterates Outperform Rating on CVS Health (CVS)

October 2, 2024 6:51 AM
Mizuho analyst Ann Hynes reiterated an Outperform rating and $66.00 price target on CVS Health (NYSE: CVS).The analyst commented: "According ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles